Skip to content

Author

L. Kushi

We have 11 of 561 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Improving Pneumococcus Vaccination Rates Among Patients With Cancer: An ASCO/CDC/CMSS-Sponsored Quality Improvement Project.

BACKGROUND Invasive pneumococcal disease poses a substantial danger to patients with cancer, who experience higher rates of infection, antimicrobial resistance, morbidity, and mortality. Pneumococcal vaccination reduces both cases of pneumonia and hospitalizations in this population. The Advisory Committee on Immunizat...

Lisa Y. Law, Andria Albert, J. Roh et al. · 0 citations
Review Open access Oct 2026

Unequal survivorship: A multi-outcome analysis of LGBTQ+ disparities among adolescent and young adult cancer survivors in the VOICE study.

359 Background: A growing literature suggests LGBTQ+ adolescent and young adult (AYA) survivors may experience more barriers to care and worse health than their non-LGBTQ+ counterparts. However, most studies have examined outcomes in isolation. To address this gap, we conducted a multi-outcome analysis. Method...

Austin R. Waters, Brittany M. Charlton, J. Mack et al. · 0 citations
Review Open access Oct 2026

Fertility counseling, preservation, and time to treatment in adolescents and young adults diagnosed with lymphoma.

Time to chemotherapy was statistically significantly longer in AYAs who received fertility counseling from a specialist but did not cryopreserve and in those who received cryopreservation (vs no specialist counseling) in females, but not in males.

Chun R. Chao, K. Ruddy, Jia Li et al. · 0 citations
Review Open access Aug 2026

THE KPROCS STUDY: A REAL-WORLD AND RESEARCH RESOURCE TO INVESTIGATE MULTILEVEL DETERMINANTS OF OVARIAN CANCER TREATMENT AND SURVIVAL

Background: Compared with non-Hispanic White (NHW) women, Black women with epithelial ovarian cancer (EOC) experience poorer survival, partly due to differences in treatment and access to care. However, these factors do not fully explain survival disparities, and outcomes among other groups remain understudied. Emergin...

E. Bandera, J. Doherty, Valerie S. Lee et al. · 0 citations
Review Open access Oct 2026

Importance of faecal sample collection in prospective cohort studies to evaluate the effect of the gut microbiome on cancer development.

The gut microbiome has been linked to cancer in many cross-sectional studies. These studies compared individuals with and without cancer, but they do not establish causation. Prospective cohort studies, with faecal samples collected before a cancer diagnosis, will be instrumental in assessing the role of the gut microb...

E. Vogtmann, Caroline Y. Um, S. Zouiouich et al. · 0 citations
Sep 2026

Detection Patterns of Breast Cancer Recurrence and Contralateral New Primaries in a Large Integrated Health System.

BACKGROUND Optimizing surveillance for the growing population of breast cancer survivors remains a challenge. Although screening guidelines for initial breast cancer are well established, current surveillance guidelines recommending routine provider examinations rely heavily on expert consensus rather than real-world d...

A. Duffens, Cecile A. Laurent, I. Ergas et al. · 0 citations
Open access Sep 2026

Genetic and cellular architecture of breast cancer risk across ancestries.

Results indicate substantial cross-ancestry sharing of breast cancer polygenic architecture, highlight a consistent contribution of regulatory variation, and identify convergent cellular contexts that motivate functional follow-up and inform expectations for the transferability and attainable performance of common-vari...

James L. Li, Maria Zanti, Jacob Williams et al. · 0 citations
Review Open access Aug 2026

Self-reported racial and ethnic discrimination in patient-provider interactions and the initiation of adjuvant therapies for breast cancer in the pathways study

Self-reported racial/ethnic discrimination in patient-provider interactions was associated with the non-initiation of hormonal therapy in women with breast cancer and the impact of this association on breast cancer prognosis.

Kevin R Bitsie, Thomas A. Pearson, M. Kwan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.